|
J Biol Chem, Vol. 275, Issue 2, 793-800, January 14, 2000
Phosphorylation of 130- and 95-kDa Substrates Associated with
Tumor Necrosis Factor- Receptor CD120a (p55)*
Soo-taek
Uh §,
Annemie
Van Linden ¶, and
David W. H.
Riches ¶ **
From the Division of Basic Sciences, Department of
Pediatrics, National Jewish Medical and Research Center,
Denver, Colorado 80206 and the Department of Biochemistry and
Molecular Genetics, Department of Medicine, Division of Pulmonary
Sciences and Critical Care Medicine, and Departments of
Pharmacology and ¶ Immunology, University of Colorado
Health Sciences Center, Denver, Colorado 80262
 |
ABSTRACT |
Cross-linking of CD120a (p55), a receptor for
tumor necrosis factor (TNF ), initiates downstream events,
including the activation of protein Ser/Thr kinases. In this report, we
have characterized two protein Ser/Thr kinase substrates that are
intrinsically associated with CD120a (p55) in mouse macrophages, and we
have investigated the mechanism involved in their phosphorylation.
pp130 and pp95 were detected by co-immunoprecipitation with CD120a
(p55) from lysates of mouse bone marrow-derived macrophages and were
phosphorylated on Ser and Thr residues during in vitro
kinase assays in the presence of [ -32P]ATP. The level
of phosphorylation of pp130 and pp95 was rapidly and transiently
increased in response to TNF in
[32P]orthophosphate-labeled macrophages, although the
level of pp130 protein associated with CD120a (p55) remained unchanged
as detected by [35S]methionine labeling. In contrast,
pp130 and pp95 were efficiently phosphorylated in in vitro
kinase assays of CD120a (p55) immunoprecipitates from unstimulated
cells, and the level of phosphorylation was rapidly and transiently
reduced in response to TNF . Both pp130 and pp95 were sensitive to
dephosphorylation with purified protein phosphatase 2A, and okadaic
acid, a PP1/PP2A inhibitor, mimicked the ability of TNF to stimulate
the phosphorylation of pp130 and pp95 in intact 32P-labeled
macrophages. Collectively, these findings suggest that pp130 and pp95
are constitutively associated with CD120a (p55) and become inducibly
phosphorylated in macrophages in response to TNF . We propose that
the underlying mechanism of their phosphorylation may involve the
inactivation of a cytoplasmic pp130/pp95 Ser/Thr phosphatase.
 |
INTRODUCTION |
Tumor necrosis factor-
(TNF )1 is a pleiotropic
cytokine that regulates many aspects of the inflammatory response, host
defense, and fibrogenesis (1-3). Cellular responses to TNF are
mediated by two cell surface receptors, designated CD120a (p55) and
CD120b (p75), which initiate distinct signaling responses, initially through protein-protein interactions between the cytoplasmic domains of
the receptors and a number of adaptor and other signaling proteins. Aggregation of CD120a (p55) facilitates the binding of TRADD to CD120a
(p55) via the death domains of both proteins (4). The binding of TRADD
enables the assembly of TNF-receptor associated factor-2, RIP, and
Fas-associated death domain protein (5, 6), which then provide
connections to the activation of c-Jun NH2-terminal kinase,
I B-kinases (IKK and ), and caspase 8, respectively (7-10).
However, whereas molecules such as TRADD, TNF-receptor associated
factor-2, RIP, and Fas-associated death domain protein play
indisputably important roles in signal transduction following ligation
of CD120a (p55), other signaling proteins, including additional Ser/Thr
kinases and their appropriate substrates, have been found to be present
in CD120a (p55) immunoprecipitates (11) or bound by glutathione
S-transferase (GST) fusion proteins containing the
cytoplasmic domain of CD120a (p55) (12). For the most part, the
identity and functions of these poorly defined proteins have remained elusive.
The ability of Ser/Thr kinases to associate with sequences present in
the cytoplasmic domains of CD120a (p55) and CD120b (p75), as well as
the related lymphotoxin- receptor, has been known for several years.
Darnay et al. (12) have characterized a Ser/Thr protein
kinase activity that binds to sequences located in the death domain of
human CD120a (p55) using fusion proteins of GST and various truncations
and deletions of the cytoplasmic domain of the receptor. Designated p60
TRAK, the kinase exhibits a preference for CD120a (p55), histone H1,
and casein, but not for CD120b (p75) or myelin basic protein. A
distinct Ser/Thr kinase activity identified as casein kinase I has also
been found to constitutively associate with the cytoplasmic region of
CD120b (p75), and its activity promotes rescue from apoptosis (13). A
similar approach employing GST fusion proteins has also been used to
characterize a Ser/Thr kinase activity that interacts with sequences
present within the cytoplasmic domain of the lymphotoxin- receptor
(14). This latter kinase also appears to be specific for the
lymphotoxin- receptor and does not trans-phosphorylate
CD120a (p55). A Ser kinase activity has also been detected in
immunoprecipitates of human CD120a (p55) from U937 cells and was found
to phosphorylate substrates of 125, 97, 85, and 60 kDa that were
co-immunoprecipitated with the receptor (11). RIP and RIP2 are 74- and
61-kDa death domain-containing proteins bearing Ser/Thr kinase domains
(15, 16) and are the only CD120a (p55)-associated kinases to be cloned although their molecular weights are distinct from other
receptor-associated kinase activities. Thus, in addition to the
previously identified proteins that interact with CD120a (p55), a
number of other proteins, including Ser/Thr kinase(s), appear to
interact with the cytoplasmic domain of the receptor.
Immunoprecipitation of mouse CD120a (p55) from mouse bone
marrow-derived macrophages co-immunoprecipitates two proteins, pp130 and pp95, that are phosphorylated on Ser and Thr residues in
vitro by a receptor-associated kinase activity. The major goal of
the work reported herein was to determine the mechanism of
phosphorylation of pp130 and pp95 and their mode of interaction with
CD120a (p55). As we will show, pp130 undergoes a rapid and transient
TNF -induced increase in phosphorylation. In addition, we provide
evidence suggestive of an indirect interaction between pp130 and pp95
with the cytoplasmic domain of CD120a (p55).
 |
EXPERIMENTAL PROCEDURES |
Materials--
C3H/HeJ mice were bred in the Biologic Resource
Center at the National Jewish Medical and Research Center and were used
throughout the study to avoid the possibility of stimulation by trace
amounts of endotoxin contaminants (17). Dulbecco's modified Eagle's medium and phosphate-free minimum essential medium (MEM) were purchased
from Whittaker Bioproducts (Walkersville, MD). Methionine-free MEM was
purchased from Life Technologies, Inc. Fetal bovine serum was obtained
from Irvine Scientific (Santa Ana, CA). Monoclonal anti-CD120a (p55)
and anti-CD120b (p75) antibodies and recombinant mouse TNF were
purchased from Genzyme (Cambridge, MA). Nonimmune hamster IgG was
obtained from Accurate Chemical and Scientific Co. (Westbury, NY). BCA
protein assay kits were purchased from Pierce.
[ -32P]ATP (>3,000 mCi/mmol),
[32P]orthophosphate (>8500 Ci/mmol), and
[35S]methionine (1175 Ci/mmol) were purchased from NEN
Life Science Products.
Macrophage Isolation and Culture--
Bone marrow-derived
macrophages were prepared from femoral and tibial bone marrow as
described previously (18). Bone marrow progenitor cells were cultured
at a density of 2.4 × 105 cells/cm2 at
37 °C in a 10% (v/v) CO2 atmosphere for 5 days in
Dulbecco's modified Eagle's medium containing 100 units/ml
penicillin, 100 µg/ml streptomycin, 10% (v/v) heat-inactivated fetal
bovine serum, and 10% (v/v) L929 cell-conditioned medium as a source
of CSF-1.
Immunoprecipitation-in Vitro Kinase Reactions--
Macrophage
monolayers were stimulated with TNF as specified under "Results"
and then rinsed with 20 mM HEPES buffer, pH 7.4, containing
150 mM NaCl. The cells were then lysed on ice with 500 µl
of Nonidet P-40 lysis buffer (50 mM Tris/HCl buffer, pH 8.0, containing 137 mM NaCl, 1% (v/v) Nonidet P-40, 10%
(v/v) glycerol, 1 mM NaF, 10 µg/ml leupeptin, 5 µg/ml
aprotinin, 1 mM Na3VO4, and 1 mM phenylmethylsulfonyl fluoride). The lysates were centrifuged at 14,000 rpm for 10 min at 4 °C to remove insoluble debris, and the supernatants were precleared with 20 µl of protein A-Sepharose beads. Twenty µl of each lysate were used for protein determination using the BCA method (19). Immunoprecipitations were
conducted by mixing equal amounts of lysate protein with 20 µl of
protein A-Sepharose beads and 3 µg of anti-CD120a (p55), anti-CD120b
(p75) antibody, or nonimmune IgG at 4 °C for 2.5 h. The beads
were washed twice with Nonidet P-40 lysis buffer and twice with PAN
buffer (10 mM Pipes buffer, pH 7.2, containing 100 mM NaCl and 21 µg/ml aprotinin). After the last wash, the beads were resuspended in 35 µl of PAN buffer and subjected to an
in vitro kinase assay with 20 µl of kinase buffer (20 mM Pipes buffer, pH 7.2, containing 10 mM
MnCl2, 20 µg/ml aprotinin, and 20 µCi of
[ -32P]ATP) at 30 °C for 20 min. The kinase
reactions were terminated by adding 20 µl of 5× Laemmli sample
buffer containing 100 mM DTT, and were boiled for 5 min,
before separating on a 7.5% SDS-PAGE gel under reducing conditions.
The separated bands were transferred to nitrocellulose membranes for
autoradiography of 32P-labeled phosphoproteins. Samples for
phosphopeptide mapping and phosphoamino acid analysis were transferred
to nitrocellulose membranes and polyvinylidene difluoride membranes, respectively.
Phosphoamino Acid Analysis and Phosphopeptide
Mapping--
Two-dimensional phosphoamino acid analysis (20) was
conducted by excising the appropriate 32P-labeled bands
from polyvinylidene difluoride membranes and subjecting them to
hydrolysis in 6 M HCl for 2 h at 110 °C. Following
lyophilization, the samples were resuspended in 10 µl of pH 1.9 buffer (2.5% (v/v) formic acid, 7.8% (v/v) acetic acid) containing
phosphotyrosine, phosphoserine, and phosphothreonine standards at a
final concentration of 5 mg/ml. One thousand cpm of each sample were
loaded on cellulose thin-layer plates (Merck, Whitehouse Station, NJ).
The first dimension electrophoresis was performed at 1.5 kV for 30 min
in pH 1.9 buffer, whereas the second dimension was electrophoresed at
1.3 kV for 20 min in pH 3.5 buffer (5% (v/v) acetic acid, 0.5% (v/v)
pyridine, and 0.5 mM EDTA). The plates were then dried,
sprayed with 2.5% (w/v) ninhydrin in acetone, and baked at 65 °C
for 20 min. The 32P-labeled threonine, serine, and tyrosine
were detected by autoradiography using high performance autoradiography
film (Amersham Pharmacia Biotech) and compared with the localization of
the authentic unlabeled standards.
For phosphopeptide mapping (20, 21), excised membranes were soaked in
0.5% (w/v) polyvinylpyrrolidone dissolved in 100 mM acetic
acid for 30 min at 37 °C. The membrane segments were then digested
with 40 µg of TPCK-trypsin for 4 h at 37 °C. The eluted
phosphoproteins were lyophilized and resuspended in 10 µl of pH 1.9 buffer, and ~1000 cpm of each sample were applied at the origin of
cellulose thin-layer plates. First dimension electrophoresis was
performed at 1.5 kV for 30 min in pH 1.9 buffer, and thin layer
chromatography for the second dimension was performed in
phosphochromatography buffer (37.5% (v/v) n-butanol, 25%
(v/v) pyridine, 7.5% (v/v) acetic acid) for 7 h. After drying the
plates, 32P-phosphopeptides were detected by
autoradiography using high performance autoradiography film (Amersham
Pharmacia Biotech).
Immunoprecipitation of 32P- and
35S-labeled Proteins--
In vivo labeling with
[32P]orthophosphate was performed using a modification of
previously described methods (22). Macrophage monolayers were incubated
in phosphate-free MEM for 1 h and then labeled with 1 mCi of
[32P]orthophosphate dissolved in phosphate-free MEM
containing 10% (v/v) dialyzed fetal bovine serum and 10% (v/v)
dialyzed L929 cell-conditioned medium for 6 h. Cells were
stimulated with TNF or medium alone as indicated under "Results"
before lysing in 1 ml of Nonidet P-40 lysis buffer. Cell lysates were
precleared with 20 µl of protein A-Sepharose beads for 20 min, and
immunoprecipitated overnight at 4 °C with 5 µg of anti-CD120a
(p55) antibody or anti-CD120b (p75) antibody and 20 µl of protein
A-Sepharose beads. The immune complexes were washed ten times with 1 ml
of Nonidet P-40 lysis buffer. After the last wash, 2× Laemmli sample
buffer containing 100 mM DTT was added, and the
radiolabeled proteins were resolved by 10% SDS-PAGE under reducing
conditions. The separated bands were transferred to nitrocellulose
membranes for autoradiography using high performance autoradiography
film (Amersham Pharmacia Biotech).
In vivo labeling with [35S]methionine
(23) was achieved by rinsing macrophage monolayers with prewarmed
Hanks' balanced salt solution containing 0.04% (w/v) sodium
bicarbonate followed by labeling with 1 mCi of
[35S]methionine dissolved in methionine-free MEM for 4-6
h. The cells were stimulated as described under "Results" after
removal of the [35S]methionine-containing media. The
samples were processed for analysis as described above for in
vivo labeling with [32P]orthophosphate.
Construction of GST Fusion Protein Expression
Vectors--
Fusion proteins comprising glutathione
S-transferase and segments of CD120a (p55) from residues
207-425 (the cytoplasmic domain) and 184-425 (the membrane-spanning
region and cytoplasmic domain) were constructed by polymerase chain
reaction and ligation into pGEX 5X-1. Polymerase chain reaction
primers were synthesized to contain restriction sites for
EcoRI and SalI at the 5'- and 3'-ends,
respectively. The upstream and downstream primers for the
construction of CD120a207-425 were of sequences
5'-GTTTAGAATTCCGATATCCCCGGTGGAG-3' and
5'-GTGGGTGTCGACTTATCGCGGGAGGCGGGTC-3', respectively. The
sequence of the upstream primer for the construction of
CD120a184-425 was
5'-CCACACACGAATTCCAGGACTCAGGTACTGCGGTG-3', and the downstream primer was the same as that used for CD120a207-425. The reaction mixtures were amplified with Pfu polymerase for 25 cycles containing full-length mouse CD120a (p55) as template with a
profile of denaturation for 1 min at 94 °C, primer annealing at
68 °C for 45 s, and extension at 75 °C for 45 s. The
polymerase chain reaction products were digested with EcoRI
and SalI and ligated into EcoRI/SalI
digested pGEX-5X-1. Plasmid DNA was transformed into DH-5 cells, and
the sequences of each construct were confirmed by automated DNA
sequence analysis. A GST-CD120207-425 fusion protein was
also constructed using the vector pGEX-2TK to introduce a
cAMP-dependent protein kinase phosphorylation motif to
enable labeling of CD120207-425 with 32P for
use in far Western blots.
The expression and purification of GST fusion proteins were carried out
with the following modifications of a previously described method (12,
24). Transformed DH-5 cells were grown to
A550 = 0.5-0.7 at 37 °C before inducing with
isopropyl-1-thio- -D-galactopyranoside to a final
concentration of 0.1 mM. After 3 h of induction, the cells were harvested and lysed with 10 mM Tris/HCl buffer,
pH 8.0, containing 150 mM NaCl, 1 mM EDTA, 100 µg/ml lysozyme, 1.5% (w/v) sarkosyl, and 1 mM
phenylmethylsulfonyl fluoride. The cell lysates were centrifuged at
10,000 rpm for 10 min at 4 °C, and the supernatants were incubated
with 1:1 (v/v) slurry of glutathione-agarose beads for 1 h at
4 °C on a rotator. The beads were washed five times with cold PBS
and stored at 4 °C. Unstimulated or TNF -stimulated cells were
lysed with Nonidet P-40 lysis buffer as described above. Equal amounts
of whole cell lysate protein were incubated with 20 µl of Sepharose
beads coated with GST-CD120a207-425, GST-CD120a184-425, or GST alone for 2.5 h at 4 °C.
In vitro kinase reactions were then conducted as described earlier.
Far Western Blotting--
A probe composed of an
NH2-terminal cAMPdependent kinase consensus
phosphorylation motif fused to CD120207-425 was prepared by phosphorylating the parent GST-PKA-CD120a207-425 fusion protein coated beads with bovine heart kinase in the presence of
[ -32P]ATP before digesting with thrombin to release
the soluble labeled probe as described in the Amersham Pharmacia
Biotech GST fusion protein technical manual. Briefly, prewashed beads
(1:1 slurry) were incubated in 20 mM Tris/HCl buffer, pH
7.5, containing 100 mM NaCl, 12 mM
MgCl2, 50 µCi of [ -32P]ATP, 50 units of
bovine heart kinase at 4 °C for 30 min. The reactions were
terminated with 5 ml of 10 mM sodium phosphate, pH 8.0, containing 10 mM sodium pyrophosphate, 10 mM
EDTA, and 1 mg/ml of bovine serum albumin. The beads were washed six
times with PBS and then were subjected to elution with thrombin (1 unit/µl) overnight at room temperature. The supernatants were
collected and used as the probe in far Western blots.
Macrophage monolayers were lysed with 500 µl of Nonidet P-40 lysis
buffer, and equal amounts of lysate protein were mixed with 5× Laemmli
sample buffer containing 100 mM DTT, boiled for 5 min, and
separated on a 7.5% SDS-PAGE gel under reducing conditions. The
separated proteins were transferred to nitrocellulose membranes and
were subjected to five cycles of denaturation/renaturation (stepwise to
reduce the concentration of guanidine-HCl from 6 to 0.937 M) in HB buffer (25 mM HEPES, pH 7.7, containing 25 mM NaCl, 5 mM MgCl2
and 1 mM DTT) as described previously (25). The blots were
saturated with HB buffer containing 5% (w/v) milk, 0.05% (v/v)
Nonidet P-40, 0.05% (v/v) Tween-20 at 4 °C overnight before adding
probe (1 × 105 cpm/ml) in H buffer (25 mM
HEPES, pH 7.7, containing 75 mM KCl, 2.5 mM
MgCl2, 0.1 mM EDTA, 1 mM DTT, 5%
(w/v) bovine serum albumin, 0.05% (v/v) Nonidet P-40, and 0.05% (v/v)
Tween-20 for 2 h at room temperature. The blots were washed five
times with H buffer (26), and then autoradiograms were prepared.
 |
RESULTS |
pp130 and pp95 Are Substrates for a CD120a (p55)-associated Protein
Kinase Activity--
Previous work has shown that several proteins
co-immunoprecipitate with CD120a (p55) and are substrates for
receptor-associated protein Ser/Thr kinase(s) (11). To define kinase
substrates that interact with CD120a (p55) in mouse macrophages, we
immunoprecipitated the receptor from monolayers of unstimulated mouse
macrophages using an antagonistic hamster monoclonal anti-mouse CD120a
(p55) antibody to prevent artifactual in vitro stimulation
of CD120a (p55)-dependent signaling, as has been shown to
occur with other anti-TNF-receptor antibodies (27, 28). The CD120a
(p55) immunoprecipitates were then subjected to an in vitro
kinase assay with [ -32P]ATP to catalyze the
phosphorylation of receptor-associated substrates by
receptor-associated kinase(s). As can be seen in Fig.
1A, a prominent phosphoprotein
with an estimated molecular mass of ~130 kDa (designated pp130) and a
less conspicuous band of ~95 kDa (designated pp95) were
co-immunoprecipitated with CD120a (p55) in unstimulated macrophages. A
third phosphoprotein of ~55 kDa was also detected. This
phosphoprotein was found to co-localize with CD120a (p55) in
anti-CD120a (p55) immunoblots using goat anti-mouse CD120a (p55)
antibody and thus may represent either phosphorylated CD120a (p55) or
an additional receptor-associated protein with a molecular mass similar
to that of CD120a (p55). Immunoprecipitation of macrophage lysates with
anti-CD120b (p75) antibody or nonimmune hamster IgG did not result in
the phosphorylation of pp130, pp95, or any other receptor-associated
substrates (Fig. 1A). Two-dimensional phosphoamino acid
analyses of excised segments of polyvinylidene difluoride membranes
obtained from CD120a (p55) immunoprecipitates revealed that both pp130
and pp95 were phosphorylated on Ser and Thr residues at ratios of 6.3:1
(n = 6) and 14.2:1 (n = 6) for pp130
and pp95, respectively. Neither phosphoprotein contained detectable
levels of phosphotyrosine (Fig. 1B).

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 1.
Ser/Thr phosphorylation of
TNF-receptor-associated proteins. A, pp130 and pp95
were co-precipitated with, and phosphorylated by, a CD120a (p55)
receptor-associated kinase. Macrophage detergent lysates were
immunoprecipitated with TNF-receptor specific antibodies and subjected
to an in vitro kinase assay in the presence of
[ -32P]ATP and analyzed by SDS-PAGE through a 7.5%
gel. Lane 1, anti-CD120a (p55); lane 2, anti-CD120b (p75); lane 3, nonimmune hamster IgG.
B, two-dimensional phosphoamino acid analysis of
[32P]pp130 and pp95. Equivalent cpm from both pp130 and
pp95 obtained by hydrolysis of excised segments of polyvinylidene
difluoride membrane were analyzed.
|
|
To investigate whether pp130 and pp95 were related phosphoproteins, we
conducted high resolution two-dimensional tryptic phosphopeptide mapping on excised segments of nitrocellulose membrane. As shown in
Fig. 2A, pp130 yielded 7 major
tryptic peptides and ~8-10 less distinct peptides that were only
apparent upon extended autoradiographic exposures. The tryptic
phosphopeptide map of pp95 (Fig. 2B) was markedly different
and exhibited only two highly phosphorylated peptides, the mobilities
of which were not superimposed with any of the phosphopeptides obtained
by tryptic hydrolysis of pp130. Extended exposure of the pp95
phosphopeptides revealed ~15 less intense 32P-labeled
tryptic phosphopeptides, which also exhibited a markedly different
pattern compared with pp130. pp130 and pp95 thus appear to be distinct
protein Ser/Thr kinase substrates that are constitutively associated
with CD120a (p55) but not CD120b (p75).
Exposure to TNF Induces a Bimodal Change in the Level of in
Vitro Phosphorylation of pp130 and pp95--
We next determined
whether the level or pattern of phosphorylation of pp130 and pp95 was
altered in response to ligation of TNF receptors with TNF .
Macrophage monolayers were incubated with TNF (10 ng/ml) for time
intervals up to 24 h prior to lysis, immunoprecipitation with
anti-CD120a (p55) antibody, and in vitro kinase reactions
with [ -32P]ATP. As can be seen in Fig.
3A, exposure to TNF induced
a bimodal change in the level of phosphorylation of both pp130 and
pp95. Following stimulation for 5-10 min, a modest, although
consistent, decrease in the level of phosphorylation of both pp130 and
pp95 was detected in comparison with unstimulated cells. However, after 30 min of incubation with TNF , the level of phosphorylation of pp130
and pp95 had returned to that of unstimulated cells and then began to
increase before peaking ~4-12 h after exposure to TNF . As shown
in Fig. 3B, the level of phosphorylation of pp130 and pp95
was increased in a concentration-dependent fashion compared with unstimulated macrophages following 18 h of exposure to
increasing concentrations of TNF (0.01-100 ng/ml). Incubation with
TNF did not result in the phosphorylation of CD120b (p75)-associated proteins following exposure for 18 h (Fig. 3 and data not shown). Phosphoamino acid analysis of pp130 and pp95 at each time point revealed no gross changes in the ratio of phosphoserine to
phosphothreonine, nor was phosphorylation of tyrosine residues seen at
any time point following stimulation with TNF (Fig.
4). In addition, we did not observe any
significant changes in the pattern of peptides phosphorylated in pp130
and pp95 following stimulation with TNF compared with unstimulated
cells (data not shown). Thus, the bimodal changes in the level of
phosphorylation of pp130 and pp95 do not appear to be associated with
gross changes in the pattern of phosphorylation of pp130 and pp95 and
are suggestive of changes in the overall level of phosphorylation of
acceptor sites.

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 3.
Regulation of phosphorylation of pp130 and
pp95 by TNF . Mouse macrophages were stimulated with TNF as
indicated, lysed in Nonidet P-40 buffer, and immunoprecipitated with
anti-CD120a (p55) antibody. The immunoprecipitates were then subjected
to an in vitro kinase assay. A, time course of
changes in phosphorylation of pp130 and pp95 in response to a fixed
concentration of TNF (10 ng/ml). B, TNF
concentration-dependent increase in the phosphorylation of
pp130 and pp95 following incubation with TNF (0.01-100 ng/ml) for
18 h.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Two-dimensional phosphoamino acid analysis of
pp130 and pp95 in macrophages stimulated with TNF
for up to 18 h. S, serine; T,
threonine; Y, tyrosine.
|
|
In Vivo Labeling with [32P]Orthophosphate and
[35S]Methionine--
To investigate the effect of TNF
receptor ligation on the level of phosphorylation in vivo,
macrophage monolayers were labeled with
[32P]orthophosphate (1 mCi for 6 h) and incubated
with TNF or medium alone for 10 min or 6 h. The cells were then
lysed, immunoprecipitated with anti-CD120a (p55) antibody, and analyzed
by SDS-PAGE and autoradiography. Immunoprecipitation with anti-CD120b
(p75) antibody was used as a control, as previously reported studies
have shown this TNF receptor to be constitutively phosphorylated
in vivo (13). As can be seen in Fig.
5A, 32P-labeled
pp130 and pp95 were detected, albeit at low levels in unstimulated
macrophages. Following incubation with TNF for 10 min, the level of
phosphorylation of pp130 and, to a lesser extent, pp95 was increased in
comparison with unstimulated cells but returned to the level of
unstimulated macrophages after 6 h exposure to TNF . As
expected, CD120b (p75) immunoprecipitates exhibited a heavily
phosphorylated band of ~80 kDa consistent with this phosphoprotein being CD120b (p75) (13) (data not shown). We also investigated the
effect of TNF on the association of pp130 protein with CD120a (p55)
by biosynthetic labeling with [35S]methionine and
co-immunoprecipitation with anti-CD120a (p55) antibody. As can be seen
in Fig. 5B, similar amounts of
[35S]methionine-labeled pp130 were associated with CD120a
(p55) in both unstimulated and TNF -stimulated cells. pp95 was not
detected in co-immunoprecipitates of
[35S]methionine-labeled cells suggesting either (i) a low
turnover rate, (ii) a low abundance, or (iii) insufficient methionine
residues to enable adequate labeling. Collectively, these findings
indicate that pp130 is constitutively associated with the CD120a (p55) receptor complex and that exposure to TNF initiates a rapid and transient increase in the level of phosphorylation of pp130, and to a
lesser extent pp95, in intact cells.

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 5.
Biosynthetic labeling with
[32P]orthophosphate (A) and
[35S]methionine (B) reveals a rapid and
transient phosphorylation of pp130 and pp95 in response to stimulation
with TNF , whereas the level of pp130
associated with the receptor complex is unchanged. A,
macrophages were labeled with [32P]orthophosphate and
stimulated with TNF for the indicated times. Lysates were
immunoprecipitated with either anti-CD120b (p75) (all lanes labeled
A) as a control or anti-CD120a (p55) (all lanes labeled
B). The positions of pp130 and pp95 are indicated by the
arrows. B, macrophages were labeled with
[35S]methionine and stimulated in the presence and
absence of TNF as indicated. pp130 was co-immunoprecipitated with
CD120a (p55). Lysates were also immunoprecipitated with nonimmune IgG
as a control as indicated.
|
|
Okadaic Acid Mimics the Increased Phosphorylation of pp130 by
TNF --
Although seemingly discordant, the findings of a decrease
in the phosphorylation of pp130 and pp95 following 10 min of
stimulation with TNF as detected with the
immunoprecipitation-in vitro kinase assay and an increase in
the phosphorylation of pp130 as detected by in vivo labeling
with [32P]orthophosphate are consistent with the
interpretation that the activity of a CD120a (p55) receptor-associated
kinase(s) is counteracted by a non-receptor-bound Ser/Thr phosphatase
that exhibits constitutive activity in the absence of TNF and that
becomes inactivated or rendered unavailable following ligation of
CD120a (p55). This model predicts that pp130 would be phosphorylated by
constitutively active receptor-associated kinase(s) subsequent to
immunoprecipitation from unstimulated cells. However, following
phosphorylation in intact cells, phosphate acceptor sites would become
occupied and less available for phosphorylation in the in
vitro kinase assay. Thus, the results from the
immunoprecipitation-in vitro kinase experiments would be
expected to be the reciprocal of the results from in vivo labeling.
To determine whether a PP2A/PP1-related Ser/Thr phosphatase was
involved in the regulation of phosphorylation of pp130 and pp95, we
have determined (i) whether the 32P-labeled pp130 and pp95
are sensitive to hydrolysis with purified PP2A, and (ii) whether
okadaic acid mimics the increase in phosphorylation of pp130 and pp95
detected in response to stimulation with TNF . To investigate the
sensitivity of pp130 and pp95 to PP2A, purified PP2A (0.2 units) was
included in the in vitro kinase assays following immunoprecipitation of CD120a (p55) from lysates of unstimulated and
TNF -stimulated (10 ng/ml, 10 min) macrophages. As can be seen in
Fig. 6A, in the presence of
PP2A, the level of phosphate incorporation into pp130 and pp95 was
significantly reduced. However, when okadaic acid (1 µM),
a PP1/PP2A inhibitor, was also included in the reaction mixture, the
level of phosphate incorporation into pp130 and pp95 was fully restored
to that seen in the absence of PP2A. The inclusion of alkaline
phosphatase in the incubation mixture also resulted in
dephosphorylation of pp130 and pp95. Thus, the phosphorylated residues
of both pp130 and pp95 are sensitive to removal by PP2A, and okadaic
acid inhibits the PP2A-dependent dephosphorylation of these
CD120a (p55)-associated phosphoproteins in vitro.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
A, sensitivity of phosphorylated pp130
and pp95 to dephosphorylation with purified PP2A and alkaline
phosphatase. Immunoprecipitates of CD120a (p55) from unstimulated
macrophages were subjected to in vitro kinase reactions in
the presence or absence of PP2A (0.2 units) or alkaline phosphatase
(0.2 units). As a control, okadaic acid (1 µM), a
PP1/PP2A inhibitor, was added as a control to verify that the reduced
level of phosphorylation of pp130 and pp95 was due to PP2A.
B, okadaic acid stimulates the phosphorylation of pp130 and
pp95 in intact [32P]orthophosphate-labeled mouse
macrophages. Macrophage monolayers were labeled with
[32P]orthophosphate (1 mCi) for 4 h and stimulated
with okadaic acid (1 µM) for the indicated time points
before lysing in Nonidet P-40 buffer. CD120a (p55) was
immunoprecipitated and separated by SDS-PAGE through a 7.5% gel.
TNF (10 ng/ml) was included as a control.
|
|
To address the question of whether an okadaic acid-inhibitable Ser/Thr
phosphatase was involved in controlling the activity of the CD120a
(p55)-associated kinase in mouse macrophages, we investigated the
effects of okadaic acid on the level of phosphorylation of pp130 and
pp95 in vivo. Macrophage monolayers were labeled with
[32P]orthophosphate and incubated with okadaic acid (1 µM) for up to 3 h or with TNF (10 ng/ml) as a
positive control. The cells were then lysed, and the level of
incorporation of 32P into pp130 and pp95 was determined by
co-immunoprecipitation with CD120a (p55). As can be seen in Fig.
6B, exposure to okadaic acid resulted in a marked increase
in the level of phosphorylation of pp130 and, to a lesser extent, pp95.
We also subjected the gel-purified 32P-labeled pp130 from
okadaic acid stimulated cells to tryptic phosphopeptide mapping and
compared the results to phosphopeptides obtained from tryptic digests
of gel purified pp130 following labeling in an in vitro
kinase assay. As can be seen in Fig. 7, the qualititative pattern or phosphopeptides between the two digests was very similar with conservation of at least seven phosphopeptides. These data thus suggest that the same protein was labeled by both techniques. Interestingly, on a semiquantitative basis, some
phosphopeptides appeared to be more heavily phosphorylated in
preparations of pp130 from 32P-labeled macrophages compared
with when the protein was labeled in the in vitro kinase
assay (e.g. phosphopeptide 3). We were unable to obtain
sufficient labeling with [32P]othophosphosphate to be
able to detect labeled phosphopeptides from unstimulated or
TNF -stimulated macrophages.

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 7.
Tryptic phosphopeptide maps of pp130
following labeling in an in vitro kinase assay using
[ -32P]ATP (A)
and biosynthetic labeling with [32P]orthophosphate
(B) in intact mouse macrophages. The
numbered arrows indicate seven superimposable tryptic
phosphopeptides.
|
|
The Okadaic Acid-sensitive pp130 and pp95 Phosphatase Is Not
Associated with the CD120a (p55) Receptor Complex--
The detection
of pp130 and pp95 Ser/Thr kinase activity in immunoprecipitates and the
reciprocal nature of the findings from in vivo labeling with
[32P]orthophosphate labeling are suggestive that the
okadaic acid-sensitive protein Ser/Thr phosphatase is not associated
with the CD120a (p55) receptor complex. To directly address this issue,
we determined the effect of okadaic acid on the pp130 kinase activity
of anti-CD120a (p55) immunoprecipitates because if the phosphatase were
bound to the receptor complex, the level of phosphorylation of pp130 and pp95 would be expected to increase in the presence of okadaic acid.
pp130 and pp95 were co-immunoprecipitated from monolayers of
unstimulated and TNF -stimulated (10 ng/ml, 10 min) macrophages and
subjected to the in vitro kinase assay in the presence of okadaic acid (1 µM). As can be seen in Fig.
8A, pp130 kinase activity was
not increased in the presence of okadaic acid, suggesting the
absence of an okadaic acid-sensitive phosphatase from the receptor
complex. To further question whether cytosolic phosphatases were
capable of dephosphorylating pp130, we incubated CD120a (p55) immunoprecipitates labeled with 32P by in vitro
kinase assay, with macrophage cytosolic extracts. As can be seen in
Fig. 8B, incubation in lysis buffer for 60 min did not
result in any significant dephosphorylation of pp130 and pp95, also
supporting the observation that a pp130/pp95 phosphatase is not
associated with the receptor complex. However, when the immunoprecipitates were incubated with cytosolic extract, pp130 and
pp95 were dephosphorylated. (Fig. 8B).

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 8.
pp130 phosphatase activity is not contained
within the receptor complex but is present in cytosolic extracts.
A, CD120a (p55) immunoprecipitates from unstimulated and
TNF -stimulated macrophages were washed and subjected to an in
vitro kinase assay in the presence or absence of okadaic acid.
B, CD120a (p55) co-immunoprecipitates containing
32P-labeled pp130 were incubated for up to 60 min at
37 °C with lysis buffer or cytosolic extract.
|
|
Mechanism of Interaction between pp130, pp95, and CD120a
(p55)--
The in vitro and in vivo findings
presented above have relied on the ability of anti-CD120a (p55)
antibody to co-immunoprecipitate a receptor complex that contains pp130
and pp95, and although the method has proven useful in delineating the
characteristics of these phosphoproteins, it did not allow us to
determine whether their interaction with CD120a (p55) was direct or
indirect. To address this question, we have adopted two approaches.
First, we constructed fusion proteins in which GST was fused to
residues 207-425 of mouse CD120a (p55). This region comprises the
entire cytoplasmic domain of the receptor. Macrophage monolayers were stimulated with TNF (10 ng/ml for 10 min) or incubated in medium alone and lysed. The cell lysates were then incubated with
GST-CD120207-425- or GST-coated Sepharose beads, washed,
and subjected to an in vitro kinase assay as described under
"Experimental Procedures." In addition, lysates were
co-immunoprecipitated with anti-CD120a (p55) monoclonal antibody and
subjected to an in vitro kinase assay as a control. As can
be seen in Fig. 9A, the
in vitro kinase assays conducted with anti-CD120a (p55)
immunoprecipitates revealed the expected pattern of phosphorylation of
pp130 and pp95 in both unstimulated and TNF -stimulated macrophages.
However, we did not detect any phosphorylated pp130 or pp95 following
co-precipitation of cell lysates with
GST-CD120a207-425-coated beads in either unstimulated or
TNF -stimulated cells. Similar results were obtained using a fusion
protein containing both the transmembrane domain and the cytoplasmic
domain (GST-CD120a184-425) (data not shown). Unlike the
lysates from unstimulated macrophages, lysates from TNF -stimulated
cells were found to support phosphorylation of residues present within
the cytoplasmic domain of CD120a (p55) as previously reported
(12),2 indicating that the
fusion proteins were capable of interacting with other cytoplasmic
proteins and/or kinase(s). These findings imply that the interaction
between CD120a (p55) and pp130 and pp95 may be indirect.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 9.
pp130 and pp95 are not directly associated
with the cytoplasmic domain of CD120a (p55). A, pp130
and pp95 were not detected by in vitro kinase assay
following affinity chromatography of macrophage lysates with
GST-CD120a207-425-coated Sepharose beads
(GST-CD120207-425). GST-coated Sepharose beads
(GST alone) served as a negative control. In contrast, both
pp95 and pp130 were detected by co-immunoprecipitation with CD120a
(p55) antibody (i/p with anti-CD120a (p55)). B,
far Western blot using 32P-labeled
CD120a207-425 as a probe. Macrophage lysates were
separated by SDS-PAGE through a 7.5% gel, electroblotted onto
nitrocellulose, and subjected to denaturation/renaturation in guanidine
hydrochloride. The blots were then probed with
[32P]CD120a207-425, washed, and exposed to
x-ray film. GST (GST alone) was used as a negative
control, and GST-CD120a207-425 was used as a positive
control.
|
|
To investigate this issue further, we conducted far Western blotting
experiments using 32P-labeled CD120a207-425 as
a probe. Equal amounts of protein from lysates of unstimulated and
TNF -stimulated cells (10 ng/ml) were separated by SDS-PAGE through a
7.5% gel, blotted onto nitrocellulose membranes, and then subjected to
denaturation followed by renaturation through a graded series of
solutions containing guanidine hydrochloride. We also subjected a
sample of GST-CD120a207-425 to the same procedure to serve
as a positive control because the cytoplasmic domain of CD120a (p55)
has been previously shown to self-associate (4, 29). The blots were
then probed with CD120a207-425 labeled to high specific
activity with 32P using bovine heart kinase in the presence
of [ -32P]ATP. As can be seen in Fig. 9B,
blotting with [32P]CD120a207-425 failed to
detect either pp130 or pp95. In contrast, self-association of the
CD120a207-425 with the labeled probe was readily detected,
indicating that the labeled probe was capable of interacting with itself.
 |
DISCUSSION |
As might be expected for a cytokine that initiates such a broad
and diverse spectrum of biological activities, the intracellular signaling mechanisms that control downstream responses to TNF have
proven to be equally complex (as reviewed in Ref. 30). In the work
presented herein, we have characterized two apparently unrelated CD120a
(p55)-associated proteins, pp130 and pp95, that are substrates for a
CD120a (p55)-associated Ser/Thr kinase. In addition, we have
investigated the mechanisms controlling the phosphorylation of pp130
and pp95 in mouse macrophages. Although the sequence and identity of
pp130 and pp95 were not determined, the apparent molecular masses of
these phosphoproteins support the contention that they are unrelated to
TRADD, TRAP1, TNF-receptor associated factor-2, or RIP, because each of
these previously cloned proteins exhibit molecular masses less than 100 kDa (4, 5, 15, 31), whereas MADD has a molecular mass of 176 kDa (32).
pp95 has a similar molecular mass to 55.11 (TRAP2) (33, 34). However,
immunoblotting of anti-CD120a (p55) co-immunoprecipitates with an
anti-TRAP2 antiserum failed to provide an indication that pp95 and
55.11(TRAP2) were related.3
Previously reported studies by VanArsdale and Ware (11) have confirmed
the existence of phosphoproteins of similar molecular mass to pp130 and
pp95 in CD120a (p55) co-immunoprecipitates from the human histiocytic
lymphoma cell line, U937. Thus, pp130 and pp95 appear to specifically
interact with CD120a (p55) and serve as substrates for a
receptor-associated kinase activity.
pp130 and pp95 were found to be phosphorylated on Ser and Thr residues
in in vitro kinase assays in unstimulated macrophages. We
specifically used an antagonistic monoclonal anti-CD120a (p55) antibody
to prevent artifactual cross-linking of CD120a (p55), pp130, pp95, and
the associated Ser/Thr kinase activity during immunoprecipitation.
These findings suggest that both proteins constitutively interact with
CD120a (p55) in the absence of ligand, a conclusion supported in the
case of pp130, by the finding of a constitutive association of
35S-labeled pp130 with CD120a (p55). Although these
findings contrast with observations made for some CD120a
(p55)-associated proteins, including TRADD and RIP for which
interaction with CD120a (p55) has been shown to occur in a
ligand-dependent fashion (4, 6), other proteins, especially
those that bind to the membrane proximal region of the cytoplasmic
domain, such as phosphatidylinositol 4,5-bisphosphate
kinase, appear to interact in a constitutive fashion, similar to pp130
and pp95 (35).
The relative amount of 35S-labeled pp130 protein associated
with CD120a (p55) was not influenced by the presence or absence of
TNF . However, the level of phosphorylation of pp130 and pp95 as seen
in [32P]orthophosphate-labeled macrophages was rapidly
and transiently increased in response to TNF , peaking at 10 min. In
contrast, when CD120a (p55) was immunoprecipitated from unlabeled cells and subjected to an in vitro kinase assay in the presence of
[ -32P]ATP, the level of phosphorylation of pp130 and
pp95 underwent a transient and concurrent decrease in response to
TNF that was also maximal at 10 min and that was followed by a
recovery and ultimately an increase in overall phosphorylation several
hours after the addition of TNF . In an attempt to reconcile these
findings, we propose that the reduced phosphorylation detected in the
in vitro kinase assays reflects increased net
phosphorylation of pp130 and pp95 in response to TNF in intact cells
prior to lysis, thereby reducing the number of phosphate acceptor
sites available for phosphorylation in vitro. Thus, the
pattern of phosphorylation in the in vitro kinase assays was
the converse of that seen using in vivo labeling with
[32P]orthophosphate.
The level of phosphorylation of protein substrates reflects a balance
of the activities of the appropriate protein Ser/Thr kinases and
phosphatases. Given the findings that the activity of the CD120a
(p55)-associated Ser/Thr kinase was detected in unstimulated cells, we
tested the hypothesis that the increased phosphorylation of pp130 and
pp95 in intact cells was mediated by a cytosolic protein Ser/Thr
phosphatase. Several lines of evidence supported this hypothesis.
First, incubation of macrophages with okadaic acid, a specific PP1/PP2A
inhibitor, was found to increase the phosphorylation of pp130, and to a
lesser extent, pp95, in intact 32P-labeled macrophages.
Consistent with this finding, okadaic acid has been shown to mimic
several TNF-signaling responses, including activation of
phosphorylation of p38mapk and p70Rsk (36, 37).
Okadaic acid also shares in common with TNF an ability to activate
NF- B (38) and induce down-modulation of TNF receptors (39).
Second, using purified 32P-labeled pp130 and pp95 as
substrates, a pp130/pp95-phosphatase activity was detected in
macrophage cytosolic extracts. Third, the pp130/pp95 phosphatase did
not appear to interact with the CD120a (p55)-receptor complex because
(i) the phosphorylation of pp130 or pp95 was not increased when okadaic
acid was added to in vitro kinase assays using
immunoprecipitates of CD120a (p55) as a source of pp130, pp95, and the
kinase, and (ii) dephosphorylation of pp130 and pp95 could be
demonstrated upon incubation with total cell cytosolic extract but was
not detected in the absence of cytosolic extract. A similar model of
rapid inactivation of a Ser/Thr phosphatase following stimulation with
TNF has been proposed by Guy et al. (36), who have
additionally shown the phosphatase to be redox- and okadaic
acid-sensitive; the identity of this phosphatase has been proposed to
be PP2A or PP1 (36, 40).
As more has been learned about the components of the TNF-receptor
complex, it has become clear that the interaction of signaling proteins
with the receptor occurs in a hierarchical fashion in which signaling
proteins recruit each other through specific and shared docking motifs.
To address the question of whether or not pp130 and pp95 were able to
directly interact with the cytoplasmic domain of CD120a (p55), we
conducted (i) in vitro kinase assays using the GST fusion
proteins containing the cytoplasmic domain of CD120a (p55) as an
affinity matrix and (ii) far Western blots using
32P-labeled CD120a207-425 as a probe. Although
predicable interactions were detected in the control studies, we were
unable to detect pp130 or pp95 using either approach. We speculate that these findings suggest that the interaction between pp130 and p995 with
CD120a (p55) is indirect and may involve either novel or previously
described adaptor proteins.
In summary, we have characterized the mechanism of phosphorylation of
two phosphoproteins that specifically interact with the TNF-receptor
CD120a (p55). Increased Ser/Thr phosphorylation of both proteins occurs
in response to stimulation of macrophages with TNF through a
mechanism that is proposed to involve inactivation of a cytosolic
Ser/Thr phosphatase, thereby enabling the receptor-associated kinase to
express dominant activity. Clearly, it remains a possibility that
either pp130 or pp95 may be the kinase.
 |
ACKNOWLEDGEMENTS |
We thank Linda Remigio and Cheryl Leu for
excellent technical assistance and Drs. Vincent Cottin, Surinder Soond,
and Ed Chan for helpful discussions during the course of this work. We
are also indebted to Dr. David Donner, Department of Physiology and Biophysics, Indiana University School of Medicine (Indianapolis, IN)
for providing anti-TRAP2 antiserum.
 |
FOOTNOTES |
*
This work was supported by United States Public Health
Service Grant HL55549 and SCOR Grant HL56556 from the NHLBI, National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported in part by a traveling grant from the Hyonam Kidney
Laboratory (Seoul, Korea).
**
To whom correspondence should be addressed: Neustadt Rm. D405,
Dept. of Pediatrics, National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206. Tel.: 303-398-1188; Fax:
303-398-1381, E-mail: richesd@njc.org.
2
Van Linden, A., Cottin, V., and Riches, D. W. H. J. Biol.Chem. in press.
3
S.-t. Uh, D. B. Donner, and D. W. H. Riches, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
TNF , tumor
necrosis factor- ;
pp130 and pp95, phosphoproteins of 130 and 95 kDa,
respectively;
RIP, receptor-interacting protein;
TRADD, TNF-receptor-associated death domain protein;
PP1/PP2A, protein
phosphatases 1 and 2A;
GST, glutathione S-transferase;
PAGE, polyacrylamide gel electrophoresis;
MEM, minimum essential medium;
Pipes, 1,4-piperazinediethanesulfonic acidDTT, dithiothreitol.
 |
REFERENCES |
| 1.
|
Beutler, B.,
and Cerami, A.
(1988)
Annu. Rev. Biochem.
57,
505-518[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Fiers, W.
(1991)
FEBS Lett.
285,
199-212[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Riches, D. W. H.
(1996)
in
The Molecular and Cellular Biology of Wound Repair
(Clark, R. A. F., ed), 2nd Ed.
, pp. 95-141, Plenum Press, New York
|
| 4.
|
Hsu, H.,
Xiong, J.,
and Goeddel, D. V.
(1995)
Cell
81,
495-504[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Hsu, H.,
Shu, H.-B.,
Pan, M.-G.,
and Goeddel, D. V.
(1996)
Cell
84,
299-308[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Hsu, H.,
Huang, J.,
Shu, H.-B.,
Baichwal, V.,
and Goeddel, D. V.
(1996)
Immunity
4,
387-396[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Kelliher, M. A.,
Grimm, S.,
Ishada, Y.,
Kuo, F.,
Stanger, B. Z.,
and Leder, P.
(1998)
Immunity
8,
297-303[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Yeh, W. C.,
Shahinian, A.,
Speiser, D.,
Kraunus, J.,
Billia, F.,
Wakeham, A.,
de la Pompa, J. L.,
Ferrick, D.,
Hum, B.,
Iscove, N.,
Ohashi, P.,
Rothe, M.,
Goeddel, D. V.,
and Mak, T. W.
(1997)
Immunity
7,
715-725[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Zhang, J.,
Cado, D.,
Chen, A.,
Kabra, N. H.,
and Winoto, A.
(1998)
Nature
392,
296-300[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Muzio, M.,
Stockwell, B. R.,
Stennicke, H. R.,
Salvesen, G. S.,
and Dixit, V. M.
(1998)
J. Biol. Chem.
273,
2926-2930[Abstract/Free Full Text]
|
| 11.
|
VanArsdale, T. L.,
and Ware, C. F.
(1994)
J. Immunol.
153,
3043-3050[Abstract]
|
| 12.
|
Darnay, B. G.,
Reddy, S. A. G.,
and Aggarwal, B. B.
(1994)
J. Biol. Chem.
269,
20299-20304[Abstract/Free Full Text]
|
| 13.
|
Beyaert, R.,
Vanhaesebroeck, B.,
Declercq, W.,
Van Lint, J.,
Vandenabeele, P.,
Agostinis, P.,
Vandenheede, J. R.,
and Fiers, W.
(1995)
J. Biol. Chem.
270,
23293-23299[Abstract/Free Full Text]
|
| 14.
|
Wu, M.-Y.,
Hsu, T.-L.,
Lin, W.-W.,
Campbell, R. D.,
and Hsieh, S.-L.
(1997)
J. Biol. Chem.
272,
17154-17159[Abstract/Free Full Text]
|
| 15.
|
Stanger, B. Z.,
Leder, P.,
Lee, T. H.,
Kim, E.,
and Seed, B.
(1995)
Cell
81,
513-523[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
McCarthy, J. V.,
Ni, J.,
and Dixit, V. M.
(1998)
J. Biol. Chem.
273,
16968-16975[Abstract/Free Full Text]
|
| 17.
|
Pace, J. L.,
Russell, S. W.,
LeBlanc, P. A.,
and Murasko, D. M.
(1985)
J. Immunol.
134,
977-981[Abstract]
|
| 18.
|
Riches, D. W. H.,
and Underwood, G. A.
(1991)
J. Biol. Chem.
266,
24785-24792[Abstract/Free Full Text]
|
| 19.
|
Smith, P. K.,
Krohn, R. I.,
Hermanson, G. T.,
Mallia, A. K.,
Gantner, F. H.,
Provenzano, M. D.,
Fujimoto, E. K.,
Goeke, N. M.,
Olson, B. J.,
and Klenk, D. C.
(1985)
Anal. Biochem.
150,
76-85[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Hunter, T.,
and Sefton, B. M.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
1311-1315[Abstract/Free Full Text]
|
| 21.
|
Van Der Geer, P.,
Luo, K.,
Sefton, B. M.,
and Hunter, T.
(1993)
in
Protein Phosphorylation
(Hardie, D. G., ed)
, pp. 38-40, Oxford University Press, Oxford, United Kingdom
|
| 22.
| Winston, B. W., and Riches, D. W. H. (1995)
155, 1525-1533
|
| 23.
|
Winston, B. W.,
Remigio, L. K.,
and Riches, D. W. H.
(1995)
J. Biol. Chem.
270,
27391-27394[Abstract/Free Full Text]
|
| 24.
|
Frangioni, J. V.,
and Neel, B. G.
(1993)
Anal. Biochem.
210,
179-187[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Vinson, C. R.,
LaMarco, K. L.,
Johnson, P. E.,
Landschulz, W. H.,
and McKinght, S. L.
(1988)
Genes Dev.
2,
801-806[Abstract/Free Full Text]
|
| 26.
|
Cavailles, V.,
Dauvois, S.,
Danielain, P. S.,
and Parker, M. G.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10009-10013[Abstract/Free Full Text]
|
| 27.
|
Sheehan, K. C.,
Pinckard, J. K.,
Arthur, C. D.,
Dehner, L. P.,
Goeddel, D. V.,
and Schreiber, R. D.
(1995)
J. Exp. Med.
181,
607-617[Abstract/Free Full Text]
|
| 28.
|
Lewis, M.,
Tartaglia, L. A.,
Lee, A.,
Bennett, G. L.,
Rice, G. C.,
Wong, G. H. W.,
Chen, E. Y.,
and Goeddel, D. V.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
2830-2834[Abstract/Free Full Text]
|
| 29.
|
Song, H. Y.,
Dunbar, J. D.,
and Donner, D. B.
(1994)
J. Biol. Chem.
269,
22492-22495[Abstract/Free Full Text]
|
| 30.
|
Darnay, B. G.,
and Aggarwal, B. B.
(1997)
J. Leukocyte Biol.
61,
559-566[Abstract]
|
| 31.
|
Song, H. Y.,
Dunbar, J. D.,
Zhang, Y. X.,
Guo, D.,
and Donner, D. B.
(1995)
J. Biol. Chem.
270,
3574-3581[Abstract/Free Full Text]
|
| 32.
|
Schievella, A. R.,
Chen, J. H.,
Graham, J. R.,
and Lin, L.-L.
(1997)
J. Biol. Chem.
272,
12069-12075[Abstract/Free Full Text]
|
| 33.
|
Dunbar, J. D.,
Song, H. Y.,
Guo, D.,
Wu, L.-W.,
and Donner, D. B.
(1997)
J. Immunol.
158,
4252-4259[Abstract]
|
| 34.
|
Boldin, M. P.,
Mett, I. L.,
and Wallach, D.
(1995)
FEBS Letts.
367,
39-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Castellino, A. M.,
Parker, G.,
Boronenkov, I. V.,
Anderson, R. A.,
and Chao, M. V.
(1997)
J. Biol. Chem.
272,
5861-5870[Abstract/Free Full Text]
|
| 36.
|
Guy, G. R.,
Cairns, J.,
Ng, S. B.,
and Tan, Y. H.
(1993)
J. Biol. Chem.
268,
2141-2148[Abstract/Free Full Text]
|
| 37.
|
Guy, G. R.,
Cao, X.,
Chua, S. P.,
and Tan, Y. H.
(1992)
J. Biol. Chem.
267,
1846-1852[Abstract/Free Full Text]
|
| 38.
|
Sun, S. C.,
Maggirwar, S. B.,
and Harhaj, E.
(1995)
J. Biol. Chem.
270,
18347-18351[Abstract/Free Full Text]
|
| 39.
|
Higuchi, M.,
and Aggarwal, B. B.
(1993)
J. Biol. Chem.
268,
5624-5631[Abstract/Free Full Text]
|
| 40.
|
Guy, G. R.,
Philp, R.,
and Tan, Y. H.
(1995)
Eur. J. Biochem.
229,
503-511[Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. J. Avdi, K. C. Malcolm, J. A. Nick, and G. S. Worthen
A Role for Protein Phosphatase-2A in p38 Mitogen-activated Protein Kinase-mediated Regulation of the c-Jun NH2-terminal Kinase Pathway in Human Neutrophils
J. Biol. Chem.,
October 18, 2002;
277(43):
40687 - 40696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Zhou, K. A. Mihindukulasuriya, R. A. MacCorkle-Chosnek, A. Van Hooser, M. C.-T. Hu, B. R. Brinkley, and T.-H. Tan
Protein Phosphatase 4 Is Involved in Tumor Necrosis Factor-alpha -induced Activation of c-Jun N-terminal Kinase
J. Biol. Chem.,
February 15, 2002;
277(8):
6391 - 6398.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|